(Q34424616)

2 August 2017

1 reference

title

Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (English)

1 reference

2 August 2017

1 reference

C Tudur Smith

1

1 reference

2 August 2017

A G Marson

series ordinal

2

1 reference

2 August 2017

P R Williamson

series ordinal

3

1 reference

2 August 2017

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

2 August 2017

published in

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

CD001769

1 reference

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Valproate in the treatment of partial epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Juvenile myoclonic epilepsy of Janz.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Absence seizures and carbamazepine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Carbamazepine versus valproate monotherapy for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Reliability of seizure classification using a semistructured interview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Juvenile myoclonic epilepsy: long-term response to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Comparison of valproic acid and phenytoin in newly diagnosed tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Sodium valproate vs phenytoin in status epilepticus: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Interobserver variability in the ILAE classification of seizures in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Monotherapy with valproate in primary generalized epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Paradoxical Intoxication,:A Complication of Anticonvulsant Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

Gastrointestinal tolerance of divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001769

10.1002/14651858.CD001769

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference